欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	PT/H/1153/002
药品名称	Cloreto de Potássio + Cloreto de Sódio Kabi
活性成分	potassium chloride 3.0 mg sodium chloride 9.0 mg
剂型	Solution for infusion
上市许可持有人	Freseniuns Kabi Pharma Portugal, Lda
参考成员国 - 产品名称	Portugal (PT)
互认成员国 - 产品名称	Belgium (BE) KCl 0.3% w/v + NaCl 0.9% w/v Fresenius Kabi, oplossing voor infusie Netherlands (NL) Kaliumchloride 0.3% w/v - Natriumchloride 0.9% w/v Fresenius Kabi, oplossing voor infusie United Kingdom (Northern Ireland) (XI) Ireland (IE) France (FR) Spain (ES) Italy (IT) Poland (PL) Latvia (LV) Potassium Chloride/ Sodium Chloride Fresenius 3 mg/9 mg/ml šķīdums infūzijām Lithuania (LT) Potassium Chloride/Sodium Chloride Fresenius 3 mg/9 mg/ml infuzinis tirpalas Estonia (EE) POTASSIUM CHLORIDE/SODIUM CHLORIDE FRESENIUS Slovenia (SI)
许可日期	2014/06/25
最近更新日期	2022/04/22
药物ATC编码	B05BB01 electrolytes
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final Product Information \| palen-KCl 0.15_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| smpcen-KCl 0.3_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| smpcen-KCl 0.15_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| labip-KCl 0.3_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| labip-KCl 0.15_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| labop-KCl 0.3_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| labop-KCl 0.15_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 Final Product Information \| palen-KCl 0.3_NaCl 0.9-may2014-cleanDate of last change:2015/04/13 PAR \| 575760_575761_20140808_PAR_GBBDate of last change:2015/04/13
市场状态	Positive